# VALSARTAN AND HYDROCHLOROTHIAZIDE
> **ANDA204687** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2026-04-23
## Drug
- **FDA Application Number:** ANDA204687
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VALSARTAN AND HYDROCHLOROTHIAZIDE
- **Generic name:** Hydrochlorothiazide
- **Active ingredients:** HYDROCHLOROTHIAZIDE; VALSARTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **First approval:** 2026-04-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204687)
---
*AI Analytics · CC0 1.0*